Literature DB >> 26460595

Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities.

Zora Novakova1, Jiri Cerny1, Cindy J Choy2, Jessie R Nedrow2, Joeseph K Choi2, Jacek Lubkowski3, Clifford E Berkman2, Cyril Barinka1.   

Abstract

Inhibitors targeting human glutamate carboxypeptidase II (GCPII) typically consist of a P1' glutamate-derived binding module, which warrants the high affinity and specificity, linked to an effector function that is positioned within the entrance funnel of the enzyme. Here we present a comprehensive structural and computational study aimed at dissecting the importance of the effector function for GCPII binding and affinity. To this end we determined crystal structures of human GCPII in complex with a series of phosphoramidate-based inhibitors harboring effector functions of diverse physicochemical characteristics. Our data show that higher binding affinities of phosphoramidates, compared to matching phosphonates, are linked to the presence of additional hydrogen bonds between Glu424 and Gly518 of the enzyme and the amide group of the phosphoramidate. While the positioning of the P1' glutamate-derived module within the S1' pocket of GCPII is invariant, interaction interfaces between effector functions and residues lining the entrance funnel are highly varied, with the positively charged arginine patch defined by Arg463, Arg534 and Arg536 being the only 'hot-spot' common to several studied complexes. This variability stems in part from the fact that the effector/GCPII interfaces generally encompass isolated areas of nonpolar residues within the entrance funnel and resulting van der Waals contacts lack the directionality typical for hydrogen bonding interactions. The presented data unravel a complexity of binding modes of inhibitors within non-prime site(s) of GCPII and can be exploited for the design of novel GCPII-specific compounds. PDB ID CODES: Atomic coordinates of the present structures together with the experimental structure factor amplitudes were deposited at the RCSB Protein Data Bank under accession codes 4P44 (complex with JRB-4-81), 4P45 (complex with JRB-4-73), 4P4B (complex with CTT54), 4P4D (complex with MP1C), 4P4E (complex with MP1D), 4P4F (complex with NC-2-40), 4P4I (complex with T33) and 4P4J (complex with T33D).
© 2015 FEBS.

Entities:  

Keywords:  NAALADase; X-ray crystallography; molecular modeling; phosphoramidate; prostate-specific membrane antigen

Mesh:

Substances:

Year:  2015        PMID: 26460595      PMCID: PMC4712110          DOI: 10.1111/febs.13557

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  43 in total

1.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 3.  Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.

Authors:  D V Ferraris; K Shukla; T Tsukamoto
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.

Authors:  Michal Navrátil; Jakub Ptáček; Pavel Šácha; Jana Starková; Jacek Lubkowski; Cyril Bařinka; Jan Konvalinka
Journal:  FEBS J       Date:  2014-06-17       Impact factor: 5.542

5.  Targeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.

Authors:  Tiancheng Liu; Jessie R Nedrow-Byers; Mark R Hopkins; Lisa Y Wu; Jeonghoon Lee; Peter T A Reilly; Clifford E Berkman
Journal:  Bioorg Med Chem Lett       Date:  2012-04-30       Impact factor: 2.823

6.  A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.

Authors:  Tanushree Ganguly; Shorouk Dannoon; Mark R Hopkins; Stephanie Murphy; Hendry Cahaya; Joseph E Blecha; Salma Jivan; Christopher R Drake; Cyril Barinka; Ella F Jones; Henry F VanBrocklin; Clifford E Berkman
Journal:  Nucl Med Biol       Date:  2015-06-09       Impact factor: 2.408

7.  Implementation and evaluation of a docking-rescoring method using molecular footprint comparisons.

Authors:  Trent E Balius; Sudipto Mukherjee; Robert C Rizzo
Journal:  J Comput Chem       Date:  2011-05-03       Impact factor: 3.376

8.  Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II.

Authors:  Doris Stoermer; Qun Liu; Monicia R Hall; Juliet M Flanary; Ajit G Thomas; Camilo Rojas; Barbara S Slusher; Takashi Tsukamoto
Journal:  Bioorg Med Chem Lett       Date:  2003-07-07       Impact factor: 2.823

9.  Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.

Authors:  Pavel Majer; Paul F Jackson; Greg Delahanty; Brian S Grella; Yao-Sen Ko; Weixing Li; Qun Liu; Keith M Maclin; Jana Poláková; Kathryn A Shaffer; Doris Stoermer; Dilrukshi Vitharana; Eric Yanjun Wang; Anthony Zakrzewski; Camilo Rojas; Barbara S Slusher; Krystyna M Wozniak; Eric Burak; Tharin Limsakun; Takashi Tsukamoto
Journal:  J Med Chem       Date:  2003-05-08       Impact factor: 7.446

10.  Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding.

Authors:  Cyril Barinka; Petra Mlcochová; Pavel Sácha; Ivan Hilgert; Pavel Majer; Barbara S Slusher; Václav Horejsí; Jan Konvalinka
Journal:  Eur J Biochem       Date:  2004-07
View more
  7 in total

1.  Quantitative Multiplex Substrate Profiling of Peptidases by Mass Spectrometry.

Authors:  John D Lapek; Zhenze Jiang; Jacob M Wozniak; Elena Arutyunova; Steven C Wang; M Joanne Lemieux; David J Gonzalez; Anthony J O'Donoghue
Journal:  Mol Cell Proteomics       Date:  2019-01-31       Impact factor: 5.911

2.  2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics.

Authors:  Ryo Nakajima; Zora Nováková; Werner Tueckmantel; Lucia Motlová; Cyril Bařinka; Alan P Kozikowski
Journal:  ACS Med Chem Lett       Date:  2018-10-24       Impact factor: 4.345

Review 3.  Metamorphosis of prostate specific membrane antigen (PSMA) inhibitors.

Authors:  Zahra Nikfarjam; Farshid Zargari; Alireza Nowroozi; Omid Bavi
Journal:  Biophys Rev       Date:  2022-01-13

4.  The calcium-binding site of human glutamate carboxypeptidase II is critical for dimerization, thermal stability, and enzymatic activity.

Authors:  Jakub Ptacek; Jana Nedvedova; Michal Navratil; Barbora Havlinova; Jan Konvalinka; Cyril Barinka
Journal:  Protein Sci       Date:  2018-09       Impact factor: 6.725

Review 5.  Radiopharmaceutical therapy in cancer: clinical advances and challenges.

Authors:  George Sgouros; Lisa Bodei; Michael R McDevitt; Jessie R Nedrow
Journal:  Nat Rev Drug Discov       Date:  2020-07-29       Impact factor: 84.694

6.  Building and rebuilding N-glycans in protein structure models.

Authors:  Bart van Beusekom; Natasja Wezel; Maarten L Hekkelman; Anastassis Perrakis; Paul Emsley; Robbie P Joosten
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-04-04       Impact factor: 7.652

7.  Chemical, Pharmacological and Computerized Molecular Analysis of Stem's Extracts of Bauhinia scandens L. Provide Insights into the Management of Diarrheal and Microbial Infections.

Authors:  Md Minarul Islam; Rashedul Alam; Hea-Jong Chung; Nazim Uddin Emon; Mohammad Fazlul Kabir; Sajib Rudra; Safaet Alam; Ahsan Ullah; Seong-Tshool Hong; Mohammed Aktar Sayeed
Journal:  Nutrients       Date:  2022-01-09       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.